Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Glenoid Reconstruction System

K-Number: K213459 · 2022-11-23

Decision Date2022-11-23
Product CodePHX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Glenoid Reconstruction System is a medical device manufactured by Medacta International S.A.. It received FDA 510(k) clearance on 2022-11-23 under approval number K213459. The device is classified under product code PHX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Glenoid Reconstruction System?

Glenoid Reconstruction System is a medical device that received FDA 510(k) clearance on 2022-11-23. It is manufactured by Medacta International S.A.. The 510(k) number is K213459.

When was Glenoid Reconstruction System approved by the FDA?

Glenoid Reconstruction System received FDA 510(k) clearance on 2022-11-23, under approval number K213459.

What company makes Glenoid Reconstruction System?

Glenoid Reconstruction System is manufactured by Medacta International S.A..

What is the FDA product code for Glenoid Reconstruction System?

The FDA product code for Glenoid Reconstruction System is PHX.

Related Clinical Trials

Other Devices by Medacta International S.A.

View all 146 devices →

Related Devices (Code: PHX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.